ARA-290
An erythropoietin-derived peptide (cibinetide) studied in clinical trials on nerve-related pain. Not FDA-approved.
- Type
- Peptide
- Research area
- Recovery research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About ARA-290
An erythropoietin-derived peptide (cibinetide) studied in clinical trials on nerve-related pain. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is ARA-290 an FDA-approved medicine?
No. ARA-290 is not an FDA-approved medicine. Research stage: Clinical trials.
Does EKO Labs sell ARA-290?
No. EKO Labs does not sell ARA-290 or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use ARA-290?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
What is the molecular formula of ARA-290?
According to PubChem (U.S. National Library of Medicine), ARA-290 has the molecular formula C51H84N16O21 and a molar mass of about 1,257.3 g/mol.
The molecule: ARA-290
Drag to rotate. Every atom and bond below comes from the public PubChem database of the U.S. National Institutes of Health; nothing is drawn by AI.
- Formula
- C51H84N16O21
- Molar mass
- 1,257.3 g/mol
- Heavy atoms
- 88
- PubChem CID
- 91810664 ↗
Source: PubChem, National Library of Medicine (public domain).
Related compounds
B7-33B7-33
A synthetic peptide derived from relaxin-2, studied in laboratory and animal research on fibrosis.
C62H98N16O22BPC-157BPC-157
A stomach-protein fragment studied mainly in animal models of tissue healing.
C38H68N10O14TB-500TB-500
A synthetic fragment of thymosin beta-4 studied in cell and animal research.